Treatment of Onychomycosis
For dermatophyte onychomycosis, offer oral terbinafine 250 mg daily as first-line treatment: 6 weeks for fingernails or 12 weeks for toenails, as it demonstrates superior efficacy and lower relapse rates compared to all alternatives 1, 2.
Treatment Selection Algorithm
Systemic Therapy (First-Line)
Terbinafine is the clear winner based on the most recent 2026 British Association of Dermatologists guideline 1. The evidence is compelling:
- Complete cure rates: 55% with terbinafine vs. 26% with itraconazole at 72 weeks 2
- Long-term mycological cure: 46% with terbinafine vs. 13% with itraconazole at 5 years 2
- Relapse rates: 23% with terbinafine vs. 53% with itraconazole 2
- Minimal drug interactions compared to azoles 2
Dosing:
Alternative Systemic Options
Itraconazole - Second choice when terbinafine is contraindicated 1:
- Continuous: 200 mg daily for 12 weeks
- Pulse therapy: 400 mg daily for 1 week/month (2 pulses for fingernails, 3 for toenails)
- Major caveat: Significant drug interactions, particularly with antiretrovirals 1
Fluconazole - Third-line option 1, 2:
- 150-450 mg weekly for 3 months (fingernails) or 6+ months (toenails)
- Less effective than terbinafine or itraconazole but better compliance with weekly dosing 2
- Mycological cure: 47-62% for toenails, 89-100% for fingernails 2
Topical Therapy
Amorolfine 5% nail lacquer - For superficial and distal disease 1:
- Apply once or twice weekly for 6-12 months
- Consider for patients where systemic therapy is contraindicated 1
The 2026 guideline explicitly recommends AGAINST griseofulvin due to long treatment duration and low efficacy 1.
Special Populations
Immunosuppressed Patients
Offer terbinafine or fluconazole - avoid itraconazole due to drug interaction risks, especially with antiretrovirals 1.
Diabetes
Offer terbinafine for dermatophyte infections 1. Consider azoles only for non-dermatophyte mould or Candida infections in patients without congestive heart failure 1.
Children (1-11 years)
Weight-based dosing 1:
- Terbinafine: 62.5 mg (<20 kg), 125 mg (20-40 kg), 250 mg (>40 kg) daily for 6 weeks (fingernails) or 12 weeks (toenails)
- Itraconazole pulse: 5 mg/kg/day for 7 days, repeated after 21-day intervals (2 courses for fingernails, 3 for toenails)
- Do NOT use griseofulvin despite it being the only licensed option 1
Monitoring Requirements
Baseline testing 2:
- Liver function tests and complete blood count for patients with:
- History of heavy alcohol consumption
- Hepatitis
- Haematological abnormalities
- Children (as terbinafine is unlicensed in pediatrics)
Consider therapeutic drug monitoring for itraconazole if compliance is questionable 1.
Critical Pitfalls to Avoid
Permanent taste disturbance: Rare but permanent side effect of terbinafine - warn all patients 2
Dermatophytoma: Dense white lesions under the nail are resistant to antifungals alone - requires physical removal first 2
Recurrence prevention 1:
- Replace or sanitize contaminated footwear
- Apply topical antifungal shoe sprays weekly or twice monthly
- Treat concomitant tinea pedis
- Screen family members
Re-evaluate at 3-6 months after treatment initiation - give further treatment if disease persists 2
Hepatotoxicity risk: Though minimal with terbinafine, serious hepatic toxicity has occurred in patients with pre-existing liver disease - avoid in active/chronic liver disease 2
When Combination Therapy Makes Sense
The 2026 guideline suggests considering combination topical + systemic therapy when response to monotherapy is likely poor 1, though specific criteria aren't detailed. This typically applies to severe disease with >60% nail involvement or matrix involvement.